Crinetics (CRNX) announced the appointment of Tobin “Toby” Schilke as CFO, effective February 28, 2025. Prior to joining Crinetics, Mr. Schilke served as CFO at Revance Therapeutics.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNX:
- Crinetics initiated with a Buy at TD Cowen
- Crinetics Pharmaceuticals: Strategic Buy Opportunity Amid Pipeline Advancements and Market Undervaluation
- Wolfe starts Crinetics at Peer Perform, believes hedge funds turning bearish
- Crinetics initiated with a Peer Perform at Wolfe Research
- Crinetics upgraded to Buy from Hold at Jefferies